| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8667993 | Journal of Cardiology | 2017 | 8 Pages |
Abstract
Combination EPA/PTV therapy significantly reduced coronary plaque volume compared to PTV therapy alone. Plaque stabilization was also reinforced by EPA/PTV therapy in particular SAP patients. The addition of EPA is a promising option to reduce residual CHD risk under intensive statin therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tetsu MD, PhD, FJCC, Kaoru MD, PhD, Hyuma MD, PhD, Yoichiro MD, PhD, Shigeo MD, PhD, FJCC, Motoyuki MD, PhD, FJCC, Eiichiro MD, PhD, Osamu MD, PhD, Hiroshi MD, PhD, Yoshinori MD, PhD, Satoshi MD, PhD, Takanori MD, PhD, Hiroki MD, PhD, Tetsuro MD, PhD,